Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

MORU’s Medicine Quality Research Group (MQRG) organised a multidisciplinary hybrid meeting at Keble College, Oxford, 3-6 July for the Wellcome Collaborative Award-funded FORESFA project (‘Forensic epidemiology and impact of substandard and falsified antimicrobials on public health’).

FORESFA conference 2022 Oxford group photo

The multidisciplinary hybrid meeting drew 53 colleagues from 12 countries, including pharmacists, forensic geneticists and chemists, modellers, sociologists, data scientists, informaticians, microbiologists, criminologists, public engagement specialists and food safety scientists, with national and international organization representatives. They met for vibrant discussions and planning for FORESFA. Those present in person went for after lunch walks, including to the Sir William Dunn School of Pathology blue plaque commemorating where penicillin was first brewed up to administer to patients (pictured).

On 6-8 July, the indefatigable MQRG held another, overlapping, multidisciplinary hybrid meeting, also at Keble, to discuss the Vaccine Identity Evaluation (VIE) project, which is evaluating devices for screening for substandard and falsified (SF) vaccines in supply chains. The VIE team, of the CTMGH, Department of Biochemistry and Department of Chemistry, Oxford and the Science and Technology Facilities Council’s Rutherford Appleton Laboratory (RAL), were joined by 60 colleagues from 11 countries including vaccine and device manufacturers, medicines regulators, virologists, chemists, physicists, forensic scientists, data scientists, police and investigators, sociologists and translational research experts. Pilot data were discussed and much progress made on future collaborative plans with a vision to bring about a step change in our ability to detect SF vaccines. The diverse devices were demonstrated at RAL and in Biochemistry and Chemistry.

- Paul Newton.

Similar stories

Advancing lab analysis of simulated samples, crucial to developing forensic techniques, is focus of FORESFA Trentino workshop

The FORESFA project's laboratory group met for a workshop in Trentino, Italy, with participants from Oxford, Edinburgh, London, and Vienna. The workshop focused on advancing the analysis of simulated samples, which are crucial to developing forensic techniques to analyse falsified medical products. Challenges in data integration, collaboration with external experts, and a workflow for the first pilot analysis of falsified samples were discussed.